273 related articles for article (PubMed ID: 24642807)
21. Vascular response and mechanical integrity of the new biodegradable polymer coated sirolimus-eluting PROLIM stent implanted in porcine coronary arteries.
Milewski K; Gorycki B; Buszman PP; Jelonek M; Beaudry D; Lapointe JM; Guy LG; Abusamra M; Pająk J; Kinasz W; Wojakowski W; Leclerc G; Gil RJ; Buszman PE
Kardiol Pol; 2012; 70(7):703-11. PubMed ID: 22825946
[TBL] [Abstract][Full Text] [Related]
22. Experimental efficacy of an everolimus eluting cobalt chromium stent.
Carter AJ; Brodeur A; Collingwood R; Ross S; Gibson L; Wang CA; Haller S; Coleman L; Virmani R
Catheter Cardiovasc Interv; 2006 Jul; 68(1):97-103. PubMed ID: 16755598
[TBL] [Abstract][Full Text] [Related]
23. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Smits PC; Kaiser C; D'Ascenzo F; Frati G; Mancone M; Genereux P; Stone GW
J Am Coll Cardiol; 2014 Feb; 63(4):299-307. PubMed ID: 24211507
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the SYNERGY with the PROMUS (XIENCE V) and bare metal and polymer-only Element control stents in porcine coronary arteries.
Wilson GJ; Huibregtse BA; Pennington DE; Dawkins KD
EuroIntervention; 2012 Jun; 8(2):250-7. PubMed ID: 22717928
[TBL] [Abstract][Full Text] [Related]
25. Vascular healing in drug-eluting stents: differential drug-associated response of limus-eluting stents in a preclinical model of stent implantation.
Steigerwald K; Ballke S; Quee SC; Byrne RA; Vorpahl M; Vogeser M; Kolodgie F; Virmani R; Joner M
EuroIntervention; 2012 Oct; 8(6):752-9. PubMed ID: 23086794
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of a novel slow-release paclitaxel-eluting stent with a bioabsorbable polymeric surface coating.
Jabara R; Chronos N; Conway D; Molema W; Robinson K
JACC Cardiovasc Interv; 2008 Feb; 1(1):81-7. PubMed ID: 19393150
[TBL] [Abstract][Full Text] [Related]
27. Six- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer.
Grube E; Sonoda S; Ikeno F; Honda Y; Kar S; Chan C; Gerckens U; Lansky AJ; Fitzgerald PJ
Circulation; 2004 May; 109(18):2168-71. PubMed ID: 15123533
[TBL] [Abstract][Full Text] [Related]
28. ComparisOn of neointimal coVerage betwEen zotaRolimus-eluting stent and everolimus-eluting stent using Optical Coherence Tomography (COVER OCT).
Kim JS; Kim BK; Jang IK; Shin DH; Ko YG; Choi D; Hong MK; Cho YK; Nam CW; Hur SH; Choi JH; Song YB; Hahn JY; Choi SH; Gwon HC; Jang Y
Am Heart J; 2012 Apr; 163(4):601-7. PubMed ID: 22520526
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the vessel healing process after everolimus-eluting stent and bare metal stent implantations in patients with ST-elevation myocardial infarction.
Yano H; Horinaka S; Watahik M; Watanabe T; Ishimitsu T
Heart Vessels; 2019 Apr; 34(4):572-582. PubMed ID: 30392104
[TBL] [Abstract][Full Text] [Related]
30. Two-year vascular responses to drug-eluting stents with biodegradable polymer versus durable polymer: An optical coherence tomography sub-study of the NEXT.
Katayama Y; Kubo T; Akasaka T; Ino Y; Kimura K; Okura H; Shinke T; Igarashi K; Kadota K; Kozuma K; Tanabe K; Nakagawa Y; Muramatsu T; Morino Y; Kimura T;
J Cardiol; 2017 Dec; 70(6):530-536. PubMed ID: 28536015
[TBL] [Abstract][Full Text] [Related]
31. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
[TBL] [Abstract][Full Text] [Related]
32. A randomized optical coherence tomography study of coronary stent strut coverage and luminal protrusion with rapamycin-eluting stents.
Moore P; Barlis P; Spiro J; Ghimire G; Roughton M; Di Mario C; Wallis W; Ilsley C; Mitchell A; Mason M; Kharbanda R; Vincent P; Sherwin S; Dalby M
JACC Cardiovasc Interv; 2009 May; 2(5):437-44. PubMed ID: 19463468
[TBL] [Abstract][Full Text] [Related]
33. Detailed comparison of intra-stent conditions 12 months after implantation of everolimus-eluting stents in patients with ST-segment elevation myocardial infarction or stable angina pectoris.
Mizoguchi T; Sawada T; Shinke T; Yamada S; Okamoto H; Kim SS; Takarada A; Yasaka Y
Int J Cardiol; 2014 Feb; 171(2):224-30. PubMed ID: 24388538
[TBL] [Abstract][Full Text] [Related]
34. Impact of Fluoropolymer-Based Paclitaxel Delivery on Neointimal Proliferation and Vascular Healing: A Comparative Peripheral Drug-Eluting Stent Study in the Familial Hypercholesterolemic Swine Model of Femoral Restenosis.
Gasior P; Cheng Y; Valencia AF; McGregor J; Conditt GB; Kaluza GL; Granada JF
Circ Cardiovasc Interv; 2017 May; 10(5):. PubMed ID: 28487355
[TBL] [Abstract][Full Text] [Related]
35. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
[TBL] [Abstract][Full Text] [Related]
36. Serial Evaluation of Vascular Response After Implantation of a New Sirolimus-Eluting Stent With Bioabsorbable Polymer (MISTENT): an optical coherence tomography and histopathological study.
Attizzani GF; Bezerra HG; Chamié D; Fujino Y; Spognardi AM; Stanley JR; Yamamoto H; Mehanna E; Wang W; Carlyle WC; McClain JB; Costa MA
J Invasive Cardiol; 2012 Nov; 24(11):560-8. PubMed ID: 23117309
[TBL] [Abstract][Full Text] [Related]
37. Outcomes with various drug-eluting or bare metal stents in patients with ST-segment-elevation myocardial infarction: a mixed treatment comparison analysis of trial level data from 34 068 patient-years of follow-up from randomized trials.
Bangalore S; Amoroso N; Fusaro M; Kumar S; Feit F
Circ Cardiovasc Interv; 2013 Aug; 6(4):378-90. PubMed ID: 23922145
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Strut Coverage at 6 Months by Optical Coherence Tomography With Everolimus-Eluting Stenting of Bare-Metal Stent Restenosis Versus Stenosis of Nonstented Atherosclerotic Narrowing (from the DESERT Study).
Picchi A; Musumeci G; Calabria P; Cresti A; Rescigno R; Aruffo A; Prati F; Limbruno U
Am J Cardiol; 2015 May; 115(10):1351-6. PubMed ID: 25772742
[TBL] [Abstract][Full Text] [Related]
39. Vascular responses to drug-eluting and bare metal stents in diabetic/hypercholesterolemic and nonatherosclerotic porcine coronary arteries.
Llano R; Winsor-Hines D; Patel DB; Seifert PS; Hamamdzic D; Wilson GJ; Wang H; Keane MG; Huibregtse BA; Wilensky RL
Circ Cardiovasc Interv; 2011 Oct; 4(5):438-46. PubMed ID: 21972400
[TBL] [Abstract][Full Text] [Related]
40. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
